We confirmed the expression of SGLT2 in pancreatic and prostate adenocarcinomas, also measuring their functional activity in fresh tumor tissue by in vitro uptake of the SGLT-specific PET tracer methyl-4-[18F] fluoro-deoxy-glucose (Me4FDG) [20]. Here, SLC5A2 is linked to neoplasm.